10-K/A: Ultralife Corporation Files Amendment to Annual Report
Annual Report Amendment
Ultralife Corporation has filed an amendment to its Form 10-K for the fiscal year ended December 31, 2025, to include omitted Part III information.
Summary
- This filing is an Amendment No. 1 to Ultralife Corporation's Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
- The amendment was filed to include information required by Items 10, 11, 12, 13, and 14 of Part III, which was originally omitted.
- The company is including this information because it will not file its definitive proxy statement within the required 120-day period after the fiscal year-end.
- The company plans to hold its 2026 Annual Stockholders Meeting on July 22, 2026, and expects to file its definitive proxy statement around June 2, 2026.
- This amendment does not alter any financial information or reflect events occurring after the original filing date.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral; it is a procedural amendment to fulfill regulatory requirements and does not contain new financial performance data or strategic updates.
Future Outlook
The company plans to file its definitive proxy statement on or about June 2, 2026, in preparation for its 2026 Annual Stockholders Meeting on July 22, 2026.
Industry Context
StockSavvy.ai notes that this filing is a procedural amendment to a Form 10-K, common for companies that need to provide Part III information and cannot rely on timely proxy statement incorporation by reference. This is a standard regulatory requirement for public companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Filing Inclusion | Inclusion of Part III information (Items 10-14) into the Form 10-K. | April 28, 2026 | Ensures compliance with SEC reporting requirements by providing necessary details on directors, executive compensation, security ownership, related party transactions, and principal accountant fees. |
Stakeholder Impact
- Shareholders: Will receive updated information regarding corporate governance, executive compensation, and security ownership, which are crucial for informed investment decisions.
- Management and Employees: The filing details executive compensation structures and policies, impacting their remuneration and equity awards.
- Regulatory Bodies: Ensures compliance with SEC filing requirements.
Next Steps
- File definitive proxy statement on or about June 2, 2026.
- Hold 2026 Annual Stockholders Meeting on July 22, 2026.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Fiscal year ended |
| 2026-03-23 | Original Form 10-K filing date |
| 2026-04-24 | Date as of which common stock outstanding and beneficial ownership information is reported |
| 2026-04-28 | Filing date of Amendment No. 1 |
| 2026-06-02 | Expected filing date of definitive proxy statement |
| 2026-07-22 | Date of 2026 Annual Stockholders Meeting |
Keywords
Ultralife Corporation, Form 10-K, Amendment, SEC Filing, Annual Report, Corporate Governance, Executive Compensation, Director Nominations, Financial Reporting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.